Insulet (Nasdaq:PODD) today hosted its Investor Day event, led by CEO Ashley McEvoy, laying out the future for the insulin ...

Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system.

Insulet Corporation PODD reported third-quarter 2025 adjusted earnings per share (EPS) of $1.24, up 37.8% from the year-ago period’s figure. The bottom line surpassed the Zacks Consensus Estimate by ...

Insulet (PODD) delivered third-quarter 2025 results that surpassed analyst predictions for both revenue and earnings. This outcome was due to meaningful expansion in its Omnipod insulin delivery ...

With the ONE U Store going out of business, we are in the process of cleaning up our access to software downloads, both free and paid. Please use the links below to access software previously provided ...

While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics ...

EMBED <iframe src="https://archive.org/embed/monthly-ascii-1993-09" width="560" height="384" frameborder="0" webkitallowfullscreen="true" mozallowfullscreen="true ...

If you cannot download a file from the Internet or save or run it using Firefox, Chrome, Edge, Opera, or other browsers on Windows 11/10; that is, when you click a link to download a file, nothing ...

Insulet ((PODD)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help ...